Catalent Invests Over $27 Million to Commercialize Zydis® Ultra, a Next Generation Oral Disintegrating Tablet

Catalent Invests Over $27 Million to Commercialize Zydis® Ultra, a Next Generation Oral Disintegrating Tablet Catalent SOMERSET, N.J. – March 7, 2019 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to invest more than $27 million […]

Read More

Blog by Norac Pharma

• With the mega pharma mergers that keep cropping up and are likely to continue into the future, what is the impact felt by CROs? As a CRO/CMO I would say that this has been a significant factor in the past but less of an issue now. This is clearly summarized in the following article […]

Read More

Seed Money is available from the National Institute of Standards and Technology for California Medical Device Manufacturers engaged in Cable and Wire Harnesses and PCBAs.

Seed Money is available from the National Institute of Standards and Technology for California Medical Device Manufacturers engaged in Cable and Wire Harnesses and PCBAs. Funding is available from the National Institute of Standards and Technology for medical device manufacturers engaged in Cable and Wire Harnesses and PCBAs to help you prepare for MedAccred Accreditation. […]

Read More

Boutique CROs: Being David in the Land of Goliaths by KCAS

BOUTIQUE CROS: BEING DAVID IN A LAND OF GOLIATHS KCAS Bioanalytical and Biomarker Services buddys-pictureIn today’s drug development arena, massive, multinational CROs dominate the industry. They offer a “one stop shop” suite of services covering Early Development to Phase IV Clinical Trials and everything in between. Although multinational CROs are the powerhouse of drug development, […]

Read More

State of the CRO Industry by KCAS

KCAS Bioanalytical and Biomarker Services Once again we find ourselves wrapping up our 2017 goals and and tallying the year’s performance. Simultaneously, we are filled with excitement looking forward to the New Year and to the promises it will bring to the pharmaceutical industry and the CRO community. According to Reuters, 2017 was one of […]

Read More

Pathology AI: Deep Learning vs Decision Trees – by Flagship Bio

Pathology AI, Deep Learning vs Decision Trees Machine learning, which provides the ability to learn a task from data (without the need of being programmed explicitly), is a key component of any Pathology AI (Artificial Intelligence) system. There are many different approaches in machine learning, reaching from simple decision trees to complex deep learning, each […]

Read More

Optical Magnification in the Age of Digital Microscopy by Flagship Bio

Optical Magnification in the Age of Digital Microscopy Figure 1: Displaying the same image on two different monitors immediately reveals the difference in optical magnification. Share this Post: Introduction January 14, 2019 – Study of the minuscule is not possible without aid of an instrument because the human retina does not possess sufficient angular resolution […]

Read More